FariasMDAlbuquerquePBSoaresPAde SDMVicenteAACarneiro-da-CunhaMG
Glycemic control: In type 2 diabetes patients, HbA1c dropped by 1.32.0% (from ~8.0% to ~6.0%) with 412 mg doses [1]
For Dementia Patients Despite some promise from early clinical trials, a meta-analysis of clinical trials concluded that ALCAR supplements are unlikely to provide a clinically meaningful benefit on the cognitive, behavioral, or functional abilities of Alzheimer's patients [1]
BPC 157 application was always combined with the application of the NOS-blocker L-NAME (NOS-blockade), and NOS-substrate, L-arginine (NO-system over-activity), given alone and/or together (L-NAME (NO-system blockade), and L-arginine (NO-system-over-activity), combined L-NAME+L-arginine (NO-system immobilization)
What Is Category 2 and Why Did It Matter
BPC-157 is a tissue repair research compound commonly evaluated in studies focused on tissue repair, tendon, ligament, and gastrointestinal pathway research